BuzzSparks.org

Valeant Pharmaceuticals International


Develops and Markets health products

Valeant Pharmaceuticals International, a specialty pharmaceutical company, engages in the development, manufacture, and marketing of a range of pharmaceutical products. It primarily offers specialty pharmaceutical and over-the-counter (OTC) products...

Founded in 1960
Employees: 2,300
Homepage:

92656 One Enterprise

Aliso Viejo
USA CA

Phone: 1-800-548-5100

J. Michael Pearson Chairman of the Board and Chief Executive Officer
Past
Rajiv De Silva President
Bhaskar Chaudhuri Management

June, 2013

Valeant to sell up to $2-billion in shares for Bausch & Lomb acquisition    theglobeandmail.com

May, 2013

Valeant Pharmaceuticals International acquired Bausch & Lomb for $8.7B

Valeant to acquire B+L for $8.7 billion in cash    medicaldevicedaily.com

May, 2010

Valeant Pharmaceuticals International acquired Aton Pharma for $318M

Valeant to buy orphan drug developer Aton for $318M    fiercebiotech.com

September, 2009

Valeant Pharmaceuticals International acquired Private Formula International Holdings for $73.4M

Valeant Pharma To Buy Australian Skin-Care Company For $73.4M    online.wsj.com

July, 2009

Valeant Pharmaceuticals International acquired Tecnofarma for $33M

Valeant Pharmaceuticals Buy Tecnofarma    tradingmarkets.com

1960

Valeant Pharmaceuticals International was founded in 1960